Assenagon Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $269M | Buy |
|
|||||
|
2025
Q2 | $222M | Sell |
|
|||||
|
2025
Q1 | $305M | Buy |
|
|||||
|
2024
Q4 | $127M | Buy |
|
|||||
|
2024
Q3 | $182M | Buy |
|
|||||
|
2024
Q2 | $135M | Sell |
|
|||||
|
2024
Q1 | $183M | Sell |
|
|||||
|
2023
Q4 | $190M | Buy |
|
|||||
|
2023
Q3 | $77.7M | Sell |
|
|||||
|
2023
Q2 | $85M | Sell |
|
|||||
|
2023
Q1 | $167M | Buy |
|
|||||
|
2022
Q4 | $88M | Buy |
|
|||||
|
2022
Q3 | $57.2M | Buy |
|
|||||
|
2022
Q2 | $41.5M | Buy |
|
|||||
|
2022
Q1 | $45.8M | Buy |
|
|||||
|
2021
Q4 | $19.1M | Sell |
|
|||||
|
2021
Q3 | $24.4M | Buy |
|
|||||
|
2021
Q2 | $5.07M | Sell |
|
|||||
|
2021
Q1 | $90.7M | Buy |
|
|||||
|
2020
Q4 | $75.5M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $21.6M | Buy |
|
|||||
|
2020
Q1 | $615K | Sell |
|
|||||
|
2019
Q4 | $10.6M | Sell |
|
|||||
|
2019
Q3 | $9.48M | Sell |
|
|||||
|
2019
Q2 | $31.8M | Buy |
|
|||||
|
2019
Q1 | $40.2M | Buy |
|
|||||
|
2018
Q4 | $13.4M | Sell |
|
|||||
|
2018
Q3 | $44.7M | Sell |
|
|||||
|
2018
Q2 | $39.3M | Buy |
|
|||||
|
2018
Q1 | $15.6M | Buy |
|
|||||
|
2017
Q4 | $14.5M | Sell |
|
|||||
|
2017
Q3 | $54.5M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $295K | Buy |
|